Germany: Pharmaceuticals Merck Teams Up with Kuraray to Supply PVA Grades

Editor: Ahlam Rais

Under the agreement, Merck and Kuraray will offer design know-how and manufacturing expertise respectively for improving the drug performance. With this deal, a wide range of PVA polymer grades will be made available in the pharma market.

Related Companies

Merck’s design know-how, in combination with Kuraray’s manufacturing expertise, will make a wide variety of PVA polymer grades for pharmaceutical applications available.
Merck’s design know-how, in combination with Kuraray’s manufacturing expertise, will make a wide variety of PVA polymer grades for pharmaceutical applications available.
(Source: Deposit Photos)

Darmstadt/Germany — Merck has recently announced that it has extended and expanded its collaboration with Kuraray Europe to exclusively supply pharmaceutical polyvinyl alcohol (PVA) grades and improvements to benefit the pharmaceutical market. PVA polymers are used as matrix/drug delivery compounds to assist in drug formulation and help active pharmaceutical ingredients enter the human body efficiently.

Merck’s design know-how, in combination with Kuraray’s manufacturing expertise, will make a wide variety of PVA polymer grades for pharmaceutical applications available. These compounds, including ones with various new properties, can help tackle pharmaceutical challenges. For instance, they can improve the controlled release of solid dosage forms and topically applied gels. The developments from this collaboration will include injectable grades with low levels of specific impurities.

PVA is a versatile polymer platform for use in developing drug formulations. Intrinsic polymer properties — molecular weight and hydrophilicity, for example — may be adjusted to meet the needs of specific formulations.

Subscribe to the newsletter now

Don't Miss out on Our Best Content

By clicking on „Subscribe to Newsletter“ I agree to the processing and use of my data according to the consent form (please expand for details) and accept the Terms of Use. For more information, please see our Privacy Policy.

Unfold for details of your consent

(ID:45666634)